Legend Biotech Corporation (LEGN)
NASDAQ: LEGN · Real-Time Price · USD
18.75
-0.30 (-1.57%)
At close: Mar 13, 2026, 4:00 PM EDT
18.58
-0.17 (-0.91%)
After-hours: Mar 13, 2026, 7:02 PM EDT
Legend Biotech Market Cap
Legend Biotech has a market cap or net worth of $3.47 billion as of March 13, 2026. Its market cap has decreased by -48.52% in one year.
Market Cap
3.47B
Enterprise Value
2.93B
1-Year Change
-48.52%
Ranking
Category
Stock Price
$18.75
Market Cap Chart
Since June 5, 2020, Legend Biotech's market cap has decreased from $4.79B to $3.47B, a decrease of -27.55%. That is a compound annual growth rate of -5.43%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 13, 2026 | 3.47B | -13.64% |
| Dec 31, 2025 | 4.02B | -32.74% |
| Dec 31, 2024 | 5.97B | -45.43% |
| Dec 29, 2023 | 10.94B | 30.89% |
| Dec 30, 2022 | 8.36B | 16.46% |
| Dec 31, 2021 | 7.18B | 92.11% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Jun 5, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Crinetics Pharmaceuticals | 3.93B |
| Centessa Pharmaceuticals | 3.85B |
| Structure Therapeutics | 3.81B |
| ADMA Biologics | 3.61B |
| ACADIA Pharmaceuticals | 3.51B |
| Dianthus Therapeutics | 3.46B |
| Corcept Therapeutics | 3.42B |
| NewAmsterdam Pharma Company | 3.29B |